HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olubanke Dzahini Selected Research

Olubanke Dzahini Research Topics

Disease

7Psychotic Disorders (Schizoaffective Disorder)
01/2024 - 01/2020
6Neutropenia
01/2023 - 01/2019
5Treatment-Resistant Schizophrenia
10/2021 - 01/2020
2Schizophrenia (Dementia Praecox)
01/2024 - 01/2022
2Infections
01/2023 - 01/2022
2Sialorrhea
01/2022 - 01/2020
2Drug-Related Side Effects and Adverse Reactions
10/2021 - 01/2017
1Tardive Dyskinesia
01/2024
1COVID-19
01/2023
1Agranulocytosis (Granulocytopenia)
01/2022
1Mental Disorders (Mental Disorder)
01/2021
1Confusion (Bewilderment)
01/2020
1Headache (Headaches)
01/2020
1Tachycardia (Tachyarrhythmias)
01/2020
1Fatigue
01/2020
1Dizziness (Lightheadedness)
01/2020
1Weight Gain
01/2020
1Constipation
01/2020
1Venous Thromboembolism
07/2018
1Atrial Fibrillation
07/2018
1Movement Disorders (Movement Disorder)
01/2015

Drug/Important Bio-Agent (IBA)

14Clozapine (Clozaril)FDA LinkGeneric
12/2023 - 01/2019
6Antipsychotic Agents (Antipsychotics)IBA
01/2024 - 01/2015
2Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2017
1valbenazineIBA
01/2024
1Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
01/2024
1deutetrabenazineIBA
01/2024
1Tetrabenazine (Nitoman)FDA Link
01/2024
1VortioxetineIBA
01/2022
1Metoclopramide (Reglan)FDA LinkGeneric
01/2022
1Paliperidone PalmitateFDA Link
01/2022
1Penfluridol (Semap)IBA
01/2022
1Vitamin KFDA Link
07/2018

Therapy/Procedure

3Therapeutics
01/2022 - 01/2015